APIXABAN IN THE TREATMENT OF ATRIAL FIBRILLATION: RANDOMIZED TRIALS AND EVERYDAY CLINICAL PRACTICE

Apixaban is the only NOA the administration of which is associated with a reduction in the incidence of both stroke and major bleeding. Therefore, apixaban is the drug of choice in patients with non-valvular AF, including elderly patients, patients with a high risk of bleeding complications, as well...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Атеротромбоз
المؤلفون الرئيسيون: O. O. Shakhmatova, E. P. Panchenko
التنسيق: مقال
اللغة:الروسية
منشور في: «REMEDIUM GROUP» Ltd. 2017-05-01
الموضوعات:
apixaban
eliquis
atrial fibrillation
cardioversion
catheter ablation
routine practice
gastrointestinal bleeding
the elderly
الوصول للمادة أونلاين:https://www.aterotromboz.ru/jour/article/view/110

الانترنت

https://www.aterotromboz.ru/jour/article/view/110

مواد مشابهة